Elsevier Introduces Nine New Life Sciences Books at Experimental Biology 2015 Conference in Boston
March 30, 2015 04:00 ET
|
Elsevier, Inc.
WALTHAM, MA--(Marketwired - March 30, 2015) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the latest...
GAP and IMI to Sign MOU to Accelerate Alzheimer's Drug Development
March 19, 2015 09:57 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON and NICE, FRANCE, March 19, 2015 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform (GAP) and the Innovative Medicines Initiative (IMI) announced today that they will sign a Memorandum of...
Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
December 04, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - December 04, 2014) - Timing is everything and when Plandaí Biotechnology (OTCQB: PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
November 17, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
November 10, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...
C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors
November 10, 2014 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven...
Plandai Biotechnology Cannabis Research Gets Green Light From Uruguay
November 05, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 05, 2014) - Plandaí Biotechnology (OTCQB: PLPL) just became one of very few companies to receive a government sanction to grow cannabis for medical research. It...
Risk-Based Monitoring: Pharma Doesn't Need to Reinvent the Wheel
November 03, 2014 05:00 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - November 03, 2014) - Encouraged by favorable FDA and EMA publications, a significantly increasing percentage of life sciences companies have begun...
Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs
October 29, 2014 09:00 ET
|
Relmada Therapeutics, Inc.
NEW YORK, NY--(Marketwired - October 29, 2014) - Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline,...
Plandai Biotechnology Marketing of First Product to Customers Should Be a Cinch With Proven Higher Bioavailability
October 17, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 17, 2014) - Plandaí Biotechnology (OTCQB: PLPL) began to lay out its initial plan this week explaining just how the company will get its first product, a green tea...